Monocyte activation in multiple sclerosis

Multiple Sclerosis

Volumn 4, Issue 3, 1998, Pages 162-168

  Reder, Anthony T ^a   Genç, Kurşad ^a   Byskosh, Paul V ^a   Porrini, Anna Maria ^a  

^a UNIVERSITY OF CHICAGO   (United States)

Author keywords

CD80; IFN ; IFN ; Microglia; Monocyte; Multiple sclerosis

Indexed keywords

INTERLEUKIN 1; INTERLEUKIN 10; MEMBRANE PROTEIN; MONOKINE; TUMOR NECROSIS FACTOR ALPHA;

ARTICLE; CELL ACTIVATION; CENTRAL NERVOUS SYSTEM; HUMAN; IMMUNOTHERAPY; MACROPHAGE; MICROGLIA; MONOCYTE; MULTIPLE SCLEROSIS; PERIPHERAL CIRCULATION;

EID: 0031706978     PISSN: 13524585     EISSN: None     Source Type: Journal    
DOI: 10.1177/135245859800400314     Document Type: Article

References (60)

1. Selmaj K, Raine CS, Cannella B, Brosnan CF. (1991) Identification of lymphotoxin and tumor necrosis factor in multiple sclerosis lesions. J Clin Invest 87: 949 - 954.
2. Ford AL, Foulcher E, Lemckert FA, Sedgwick JD. (1996) Microglia induce CD4 T lymphocyte final effector function and death. J Exp Med 184: 1737 - 1745.
3. Salmaggi A, Sandberg-Wollheim M. (1993) Monocyte phenotype in blood and cerebrospinal fluid: compartment-specific pattern is unrelated to neurological disease. J Neurol Sci 120: 201 - 207.
4. Hall GL, Compston A, Scolding NJ. (1997) Beta-interferon and multiple sclerosis. Trends Nourosci 20: 63 - 67.
5. Menendez-Iglesias B et al. (1997) Analysis of B7-1 and B7-2 costimulatory ligands in cultured mouse microglia: Up regulation by interferon-gamma and lipopolysaccharide and downregulation by interleukin-10, prostaglandin E2 and cyclic AMP-elevating agents J Neuroimmunol 72: 83 - 93.
6. Crawford RM et al. (1994) Macrophage activation: A riddle of immunological resistance. In: Macrophage-Pathogen Interactions. BS Zwilling, TK Eisenstein (eds.). Marcel Dekker, Inc., New York. pp. 29 - 46.
7. Reder AT, Arnason BGW. (1985) Immunology of multiple sclerosis. In: Handbook of Clinical Neurology: Demyelinating Diseases. PJ Vinken, GW Bruyn, HL Klawans. JC Koetsier (eds.). Elsevier Science Publishers: Amsterdam. pp. 337 - 395.
8. Baxevenis CN, Reclos GJ, Papamichail M. (1990) Decreased HLA-DR antigen expression on monocytes causes impaired suppressor cell activity in multiple sclerosis, J Immunol 144: 4166 - 4171.
9. Ransohoff RM, Tuohy VK, Barna BP, Rudick RA. (1992) Monocytes in active multiple sclerosis: intact regulation of HLA-DR density in vitro despite decreased HLA-DR density in vivo. J Neuroimmunol 37: 169 - 176.
10. + B cells in active multiple sclerosis, and reversal by IFNβ-1b therapy. J Clin Invest 99: 2664 - 2671.
11. Reder AT. (1991) IFNβ and IFNγ modify expression of monocyte surface proteins. J Interferon Res 11(Suppl 1): S119.
12. Soilu-Hänninen M, Salmi A, Salonen R. (1995) Interferon-β downregulates expression of VLA-4 antigen and antagonizes interferon-γ-induced expression of HLA-DQ on human peripheral blood monocytes. J Neuroimmunol 60: 99 - 100.
13. Kuchroo VK et al. (1995) B7-1 and B7-2 costimulatory molecules activate differentially the Th1/Th2 developmental pathways: application to autoimmune disease therapy. Cell 80: 707 - 718.
14. Mattson DH, Roos RP, Arnason BGW. (1980) Isoelectric focusing of IgG eluted from multiple sclerosis, subacute sclerosing panencephalitis and normal brains. Nature 287: 335 - 337.
15. Rieckmann P. (1997) The effects of 1FN-β on cytokines and immune responses. In: Interferon Therapy of Multiple Sclerosis. AT Reder (ed.) Marcel Dekker, Inc., New York. pp. 161 - 191.
16. Rieckmann P et al. (1994) Cytokine mRNA levels in mononuclear blood cells from patients with multiple sclerosis. Neurology 44: 1523 - 1526.
17. Dyskosh PV, Reder AT. (1996) Interferon-β effects on cytokine mRNA in peripheral mononuclear cells in multiple sclerosis. Mult Scler 1: 262 - 269.
18. Martino G et al. (1997) Tumor necrosis factor α and its receptors in relapsing-remitting multiple sclerosis. J Neurol Sci (In press)
19. Matusevicius D et al. (1996) Multiple sclerosis: the proinflammatory cytokines lymphotoxin-α and tumor necrosis factor-α are upregulated in cerebrospinal fluid mononuclear cells. J Neuroimmunol 66: 115 - 123.
20. Matusevicius D et al. (1997) IL-12 and perform mRNA expression is augmented in blood mononuclear cells in multiple sclerosis in response to myelin basic protein. J Neuroimmunol Submitted:
21. Maimone D, Gregory S, Arnason BGW, Reder AT. (1991) Cytokine levels in the cerebrospinal fluid and sera of patients with multiple sclerosis. J Neuroimmunol 32: 67 - 74.
22. Sharief MK, Thompson EJ. (1992) In vivo relationship of tumor necrosis factor-α to blood-brain barrier damage in patients with active multiple sclerosis, J Neuroimmunol 38: 27 - 34.
23. + T cells via CD40 ligand. Proc Natl Acad Sci USA 94: 599-603.
24. Dore-Duffy P et al. (1986) Prostaglandin release in multiple sclerosis: correlation with disease activity. Neurology 36: 1587 - 1590.
25. 1 affect monokine secretion: relevance to monocyte activation in multiple sclerosis. Cell Immunol 157: 428 - 438.
26. Maimone D, Reder AT, Gregory S. (1993) T cell lymphokine-induced secretion of cytokines by monocytes from patients with multiple sclerosis. Cell Immunol 146: 96 - 106.
27. Imamura K, Suzumura A, Hayashi F, Marunouchi T. (1993) Cytokine production by peripheral blood monocytes/macrophages in multiple sclerosis patients. Acta Neurol Scand 87: 281 - 285.
28. Porrini AM, Gambi D, Reder AT. (1995) Interferon effects on interleukin-10 secretion. Mononuclear cell response to interleukin-10 is normal in multiple sclerosis patients. J Neuroimmunol 61: 27 - 34.
29. Rudick RA et al. (1996) Interferon beta induces interleukin-10 expression: Relevance to multiple sclerosis. Ann Neurol 40: 618 - 627.
30. Shakir S, Byskosh PV, Reder AT. (1994) Interferon-β induces interleukin-10 mRNA in mononuclear cells (MNC). Neurology 44(Suppl 2): A211 - 212.
31. Vartanian T, Li Y, Zhao M, Stefansson K. (1995) Interferon-gamma-induced oligodendrocyte cell death: implications for the pathogenesis of multiple sclerosis. Mol Med 1: 732 - 743.
32. Villiger PM, Geng Y, Lotz M. (1993) Induction of cytokine expression by leukemia inhibitory factor. J Clin Invest 91: 1575 - 1581.
33. Wang Z, Ren SG, Melmed S. (1996) Hypothalamic and pituitary leukemia inhibitory factor gene expression in vivo: a novel endotoxin-inducible neuro-endocrine interface. Endocrinology 137: 2947 - 2953.
34. Matusevicius D et al. (1997) Influence of IFN-β1b (betaferon) on cytokine mRNA profiles in blood mononuclear cells and plasma levels of soluble VCAM-1 in multiple sclerosis. European J Neurol Submitted:
35. Wingren AG et al. (1993) Monocyte-regulated IFN-γ production in human T cells involves CD2 signaling. J Immunol 151: 1328-1336.
36. Rieckmann P et al. (1995) Tumor necrosis factor-α messenger RNA expression in patients with relapsing-remitting multiple sclerosis is associated with disease activity. Ann Neurol 37: 82 - 88.
37. Rudick RA et al. (1996) Interferon beta induces interleukin-10 expression: relevance to multiple sclerosis. Ann Neurol 40: 618 - 627.
38. Kilinç M, Karabudak R, Saatçi I. (1998) The effects of IFN-β on cerebrospinal fluid and serum levels of tumor necrosis factor alpha and soluble intercellular adhesion molecule-1; MRI and clinical findings. Mult Scler In press:
39. Noronha A, Richman DP, Arnason BGW. (1980) Detection of in vivo stimulated cerebrospinal fluid lymphocytes by flow cytometry in patients with multiple sclerosis. N Engl J Med 303: 713 - 717.
40. Fredrikson S et al. (1994) Multiple sclerosis: occurrence of myelin basic protein peptide-reactive T cells in healthy family members. Acta Neurol Scand 89: 184 - 189.
41. Lassmann H, Suchanek G, Ozawa K. (1994) Histopathology and the blood-cerebrospinal fluid barrier in multiple sclerosis. Ann Neurol 36: S42 - S46.
42. Hauser SL et al. (1990) Cytokine accumulations in CSF of multiple sclerosis patients: Frequent detection of interleukin-1 and tumor necrosis factor but not interleukin-6. Neurology 40: 1735 - 1739.
43. Araga S, Takai H, Takahashi K. (1991) Interleukin-6 levels in the cerebrospinal fluid of patients with multiple sclerosis. Jpn J Psychiatry 45: 879 - 883.
44. Tsukada N et al. (1991) Tumor necrosis factor and interleukin-1 in the CSF and sera of patients with multiple sclerosis. J Neurol Sci 102: 230 - 234.
45. Sharief MK, Hentges R. (1991) Association between tumor necrosis factor-α and disease progression in patients with multiple sclerosis. N Engl J Med 325: 467 - 472.
46. Calabresi PA et al. (1996) Cytokine mRNA expression changes in CSF cells from multiple sclerosis patients treated with betaseron. Neurology 46: A165.
47. Traugott U, Reinherz EL, Raine CS. (1983) Multiple sclerosis. Distribution of T cells, T cell subsets and lapositive macrophages in lesions of different ages. J Neuroimmunol 4: 201 - 221.
48. Hofman FM et al. (1986) Immunoregulatory molecules and IL2 receptors identified in multiple sclerosis brain. J Immunol 136: 3239 - 3245.
49. Vartanian T. (1997) Interferons and the central nervous system glia. In: Interferon Therapy in Multiple Sclerosis. AT Reder (ed.). Marcel Dekker, Inc: New York. pp. 95 - 113.
50. Rodriguez M, Scheithauer B. (1994) Ultrastructure of multiple sclerosis. Ultrastructural Pathology 18: 3 - 13.
51. Traugott U, Lebon P. (1988) Multiple sclerosis: involvement of interferons in lesion pathogenesis. Ann Neurol 24: 243 - 251.
52. Prineas JW. (1985) The neuropathology of multiple sclerosis. In: Demyelinating Diseases. PJ Vinken, GW Bruyn, HL Klawans, JC Koetsier (eds.). Elsevier Science Publishing Co., Inc: New York. pp. 213 - 257.
53. Sriram S, Rodriguez M. (1997) Indictment of the microglia as the villain in multiple sclerosis. Neurology 48: 464 - 370.
54. Li H, Cuzner ML, Newcombe J. (1996) Microglia-derived macrophages in early multiple sclerosis plaques. Neuropathol Appl Neurobiol 22: 207 - 215.
55. Williams KC, Ulvestad E, Hickey WF. (1994) Immunology of multiple sclerosis. Clin Neurosci 2: 229 - 245.
56. + current expression in cultured oligodendrocytes. J Membr Biol 124: 127 - 137.
57. Gordon S. (1995) The macrophage. BioEssays 17: 977 - 986.
58. Perry VH, Andersson P-B, Coffey PJ, Gordon S. (1992) Macrophage-microglia responses to excitotoxin-induced degeneration in the central nervous system. In: Mononuclear Phagocytes. Biology of Monocytes and Macrophages. RV Furth (ed.). Kluwer Academic Publishers: Boston, pp. 37 - 44.
59. Reder AT. (1998) Neural regulation of the immune system. In: Clinical Neuroimmunology. Antel J, Hartung H-P, Birnbaum G (eds.). Blackwell Science: Malden, pp.55 - 71.
60. Lucchinetti CF, Brück W, Rodriguez M, Lassmann H. (1996) Distinct patterns of multiple sclerosis pathology indicates heterogeneity in pathogenesis. Brain Pathol 6: 259 - 274.